UTI Innovation Fund Regular Growth

  • Equity - Other
  • Equity
  • Very High Risk

Explore On

Dhan Logo

Rating:

Rating Star

Key Metrics

Aum

₹757.56 Cr

Expense Ratio

2.28%

Exit Load

1.00%

Min. Investment

₹5,000.00

Min. SIP

₹500.00

Launch Date

13 Oct 2023

CAGR Returns

PeriodAbsolute(%)Annualised(%)
1 Month-5.09%--
3 Months+9.31%--
6 Months-11.21%--
1 Year-13%-13%
2 Years---3.4%
3 Years--0%
5 Years--0%
Since Launch+1.63%+0.61%

Holdings as on 14 June 2026

NameValue (₹Cr)Holding %
Eternal
62.588.46
Info Edge (India)
59.218.00
MTAR Technologies
56.787.67
Affle 3i
40.755.51
One 97 Communications
39.265.31
Delhivery
32.404.38
PB Fintech
30.654.14
RateGain Travel Technologies Ltd
30.444.11
Acutaas Chemicals
29.073.93
FSN E-Commerce Ventures Ltd
28.573.86

Morning Star Rating

Rating:

Rating Star

Risk

High

Return

Risk & Volitility

0.00

Sharpe Ratio

0.00%

Std. Deviation

--

Tracking Error

--

Alpha

--

Beta

About Fund

The scheme intends to provide medium to long-term capital appreciation through investment primarily in growth and innovation-oriented equity and equity-related instruments. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.

The UTI Innovation Fund Regular Growth has an AUM of 757.56 crores & has delivered CAGR of 0.00 in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.28%. The minimum investment in UTI Innovation Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 500.

As per morningstar the risk & return rating of the fund are High & respectively.

The fund has a present cash holding of %. The top holdings of the fund include Eternal, Info Edge (India), MTAR Technologies, Affle 3i.

The major sectors where the fund is invested are Software & Programming, Computer Services, Misc. Capital Goods, Business Services.

Some of the similar funds are DSP Quant Fund Regular Growth, LIC MF Manufacturing Fund Regular Growth, UTI Innovation Fund Regular Growth, Motilal Oswal Manufacturing Fund Regular Growth, Mahindra Manulife Manufacturing Fund Regular Growth. UTI Innovation Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.

FAQs

According to the morning star rating UTI Innovation Fund Regular Growth has a High risk & return.

UTI Innovation Fund Regular Growth is managed by Nitin Jain.

The expense ratio of UTI Innovation Fund Regular Growth is 2.28%.

The 5 year annualized return on UTI Innovation Fund Regular Growth is 0.00% & it has generated -13.00% in the last 1 year.

The minimum investment in UTI Innovation Fund Regular Growth is 5000 Rs.

UTI Innovation Fund Regular Growth has an AUM of 757.56 crores.